View article

The Australian Treatment Outcomes Profile (ATOP) was developed as a clinical tool for monitoring the substance use, health and wellbeing of clients in alcohol and other drug treatment. This is the first psychometric validation of the ATOP in a cannabis‐dependent treatment population.

A total of 128 individuals with cannabis dependence enrolled in an outpatient randomised controlled trial were administered the ATOP and gold‐standard health and wellbeing questionnaires once by clinicians and once by researchers at baseline. Concurrent validity was assessed by testing ATOP Psychological Health, Physical Health and Quality of Life questions against concurrently administered gold‐standard questionnaires: the Short Form 36 Health Survey (SF‐36), the 21‐item Depression, Anxiety and Stress Scale (DASS‐21) and the Sheehan Disability Scale (SDS). Interrater …